Crossref
MYCN amplification suppresses PD-L1 and CXCL10 to drive an immunosuppressive microenvironment in neuroblastoma
Oncotarget · 18.11.2026 · 17 (1) · 538-554
DOI: 10.18632/oncotarget.28924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, erschienen am 18.11.2026. Verfasst von Jingbo Qiao und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Qiao, J., Chung, C. D., Cochran, E. D., & Chung, D. H. (2026). MYCN amplification suppresses PD-L1 and CXCL10 to drive an immunosuppressive microenvironment in neuroblastoma. Oncotarget, 17(1), 538-554. https://doi.org/10.18632/oncotarget.28924
Vancouver
Qiao J, Chung CD, Cochran ED, Chung DH. MYCN amplification suppresses PD-L1 and CXCL10 to drive an immunosuppressive microenvironment in neuroblastoma. Oncotarget. 2026;17(1):538-554. doi:10.18632/oncotarget.28924
BibTeX
@article{Qiao2026,
author = {Qiao, Jingbo and Chung, Camryn D. and Cochran, Elizabeth D. and Chung, Dai H.},
title = {MYCN amplification suppresses PD-L1 and CXCL10 to drive an immunosuppressive microenvironment in neuroblastoma},
journal = {Oncotarget},
year = {2026},
volume = {17},
number = {1},
pages = {538--554},
doi = {10.18632/oncotarget.28924}
}
EUVIMED